Cite

HARVARD Citation

    Eberl, A. et al. (n.d.). P600 Ustekinumab for Crohn's disease: a nationwide real-life observational cohort study from Finland. Journal of Crohn's and colitis. pp. S415-S416. [Online]. 
  
Back to record